A. “Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R21),” (PA-13-157, a reissue of PA-10-023, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 15, June 15, and Oct. 16).
grants.nih.gov/grants/guide/pa-files/PA-13-157.html
B. “Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R21/R33),” (PA-13-158, a reissue of PA-10-024, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 15, June 15, and Oct. 16).
